GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » Float Percentage Of Total Shares Outstanding

QHSLab (QHSLab) Float Percentage Of Total Shares Outstanding : 62.28% (As of May. 26, 2024)


View and export this data going back to 1990. Start your Free Trial

What is QHSLab Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, QHSLab's float shares is 6.37 Mil. QHSLab's total shares outstanding is 10.22 Mil. QHSLab's float percentage of total shares outstanding is 62.28%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, QHSLab's Insider Ownership is 69.81%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, QHSLab's Institutional Ownership is 0.00%.


QHSLab Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

QHSLab's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=6.37/10.22
=62.28%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QHSLab (QHSLab) Business Description

Industry
Traded in Other Exchanges
N/A
Address
901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. It is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
Executives
Troy James Grogan director, 10 percent owner, officer: CEO/Director 5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin director, 10 percent owner, officer: CEO & Chairman 90 JOHN STREET, SUITE 626, NEW YORK NY 10038